These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 8578698

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Duolip Forte--experience during a 6-month period of administration].
    Toschnerová H, Ceska R, Sobra J, Traurig J.
    Cas Lek Cesk; 1993 May 18; 132(10):308-10. PubMed ID: 8513467
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Use of etofyllinclofibrate (Duolip Forte) in combined hyperlipidemia].
    Hrebícek J, Skottová N, Chmela Z, Hrbková M.
    Cas Lek Cesk; 1995 Mar 08; 134(5):141-4. PubMed ID: 7728839
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Bile lipid composition in subjects with blood lipid disorders (types II and IV). Effect of a new hypolipemic drug (Etofibrate)].
    Altomonte L, Mingrone G, Ghirlanda G, Manna R, Rebuzzi A, Pala MA, Greco AV.
    Minerva Med; 1980 Feb 11; 71(4):273-8. PubMed ID: 7354946
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Plafibride treatment of hyperlipidemias type II and IV].
    Soler J, Vinzia C, Gómez JM, Morató J.
    Med Clin (Barc); 1984 May 19; 82(19):840-2. PubMed ID: 6738212
    [No Abstract] [Full Text] [Related]

  • 14. Pirifibrate in the treatment of hyperlipoproteinemia: types IIa, IIb, and IV.
    Lopez Rodriguez J, Martorell J.
    Clin Ther; 1980 May 19; 3(4):234-41. PubMed ID: 7273061
    [Abstract] [Full Text] [Related]

  • 15. Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial.
    Derosa G, Cicero AE, Bertone G, Piccinni MN, Ciccarelli L, Roggeri DE.
    Clin Ther; 2004 Oct 19; 26(10):1599-607. PubMed ID: 15598476
    [Abstract] [Full Text] [Related]

  • 16. Treatment of hyperlipoproteinemia type II with etofibrate.
    Gustafson A.
    Int J Clin Pharmacol Biopharm; 1979 Dec 19; 17(12):498-502. PubMed ID: 528096
    [Abstract] [Full Text] [Related]

  • 17. Plafibride treatment and serum lipids in hyperlipoproteinemias.
    Rodriguez F, López IM, Jover E.
    J Med; 1987 Dec 19; 18(3-4):153-63. PubMed ID: 3323393
    [Abstract] [Full Text] [Related]

  • 18. [Therapy with fibrates and vitamin D metabolism].
    Wilczek H, Sobra J, Ceska R, Justová V, Procházková R, Kvasilová M, Jůzová Z.
    Cas Lek Cesk; 1993 Oct 25; 132(20):630-2. PubMed ID: 8269466
    [Abstract] [Full Text] [Related]

  • 19. Clinical experience with bezafibrate.
    Schubotz R, Schneider J, Hausmann L, Mühlfellner G, Mühlfellner O, Kaffarnik H.
    Artery; 1980 Oct 25; 8(6):553-9. PubMed ID: 7259534
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.